Overview

Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus

Status:
Active, not recruiting
Trial end date:
2021-12-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterise long-term safety and tolerability of intravenous anifrolumab.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Collaborator:
PRA Health Sciences